Home

uvoz Datum Svest teva share price bloomberg dubok studija uviti

Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia

Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars -  BNN Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg

Teva's Links to Opioid Epidemic May Triple Funding Costs - Bloomberg
Teva's Links to Opioid Epidemic May Triple Funding Costs - Bloomberg

Teva collapse continues on Wall Street - Globes
Teva collapse continues on Wall Street - Globes

Teva trades lower after Jefferies cuts rating to Hold | Seeking Alpha
Teva trades lower after Jefferies cuts rating to Hold | Seeking Alpha

Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg

Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg

HSBC downgrades Teva on uncertainty surrounding DOJ's reported generic drug  investigation
HSBC downgrades Teva on uncertainty surrounding DOJ's reported generic drug investigation

Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg

Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters

Pharma Industry Champion Bloomberg: Generic Drugs Could Be Harmful - The  Official Myti-Herbs Online Store
Pharma Industry Champion Bloomberg: Generic Drugs Could Be Harmful - The Official Myti-Herbs Online Store

Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement -  Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg

The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg

Building on Strong First Quarter, Teva Raises 2018 Outlook | Ctech
Building on Strong First Quarter, Teva Raises 2018 Outlook | Ctech

Teva stock drops after conspiracy allegations on hiking drug prices
Teva stock drops after conspiracy allegations on hiking drug prices

Teva CEO Steps Down After Patent Losses, Bribery Settlement; Stock Dives |  Stock News & Stock Market Analysis - IBD
Teva CEO Steps Down After Patent Losses, Bribery Settlement; Stock Dives | Stock News & Stock Market Analysis - IBD

The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg

Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg

Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)

Teva's Working With Evercore to Review Debt Options - Bloomberg
Teva's Working With Evercore to Review Debt Options - Bloomberg

Berkshire's 4th Quarter Buy Teva Appears Cheap And Troubled
Berkshire's 4th Quarter Buy Teva Appears Cheap And Troubled

Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg

Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) |  Seeking Alpha
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha

Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement -  Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg

Allergan becomes largest shareholder in Teva - Globes
Allergan becomes largest shareholder in Teva - Globes

Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns -  Bloomberg
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg

Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech